Narrow your search
Listing 1 - 10 of 29 << page
of 3
>>
Sort by

Dissertation
Role of metabolic reprogramming in tumor adaptation to anti-angiogenic therapy
Author:
Year: 2015

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Anti-Angiogenesis Drug Discovery and Development.
Authors: ---
ISBN: 0128039647 0128039639 9780128039649 9780128039632 Year: 2014 Publisher: Amsterdam, Netherlands

Loading...
Export citation

Choose an application

Bookmark

Abstract

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews ha


Book
Les anti-vasculaires dans l'approche anticancéreuse
Authors: --- ---
Year: 2016 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Les VDA constituent une nouvelle classe d'agents anticancéreux, ciblant les vaisseaux sanguins préexistants au sein de la tumeur. Ils induisent une diminution du flux sanguin tumoral et une nécrose au centre de la tumeur laissant une bordure de cellule viable à la périphérie, ce qui provoque une repousse de la tumeur. Ce phénomène constitue une limite dans l'utilisation des VDA en monothérapie. Des nombreuses associations aux VDA permettant d'augmenter leur efficacité sont en cours d'évaluations dans les essais cliniques et les résultats sont très encourageants. A ce titre, nous pouvons évoquer l'association de VDA avec les agents de la chimiothérapie, avec la radiothérapie, ou encore avec les agents anti-angiogéniques. Parmi les cancers les plus étudiés, on peut citer le cancer du poumon non à petites cellules (SNCLC), le Cancer anaplasique de la thyroïde, le cancer de la prostate ou le cancer rénal. Nous détaillerons donc, dans ce mémoire, les différentes combinaisons citées ci-dessus. Vascular Disrupting agents or « VDa » constitute a new class of anticancer agent, targeting existing blood vessels within the tumor. They induce tumor blood flow shutdown and necrosis in the center of the tumor and leave a rim of viable cells in the periphery, which causes a regrowth of the tumor. This phenomenon is a limitation in the use of VDA as monotherapy. Many clinical trials associating VDA to chemo or radio-therapy, or anti-angiogenic are ongoing with promising results. The most studied cancers include non-small cell lung cancer (NSCLC), anaplastic thyroid cancer, prostate cancer or renal cancer. In this work, combinations of those above listed associations and cancer types are being described.


Book
Angiogenesis & therapeutic targets in cancer
Authors: --- ---
ISBN: 1608050076 Year: 2010 Publisher: [S.l.] : Bentham e Books,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs that target antiangiogenic cascade in different forms of cancers like breast cancer, multiple myeloma, renal carcinoma, gastrointestinal, prostate and lung cancer.


Book
Anti-angiogenesis drug discovery and development.
Authors: ---
ISBN: 1681081555 9781681081557 Year: 2016 Publisher: Sharjah Bentham Science Publishers

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Angiogenèse et anti-angiogenèse
Author:
ISBN: 9782918172246 Year: 2009 Publisher: Rueil-Malmaison : Wolters Kluwer Health, Lippincott Williams & Wilkins,.

Antiangiogenic cancer therapy.
Authors: --- ---
ISBN: 0849327997 9780849327995 Year: 2008 Publisher: Boca Raton CRC

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Research Directions in Tumor Angiogenesis
Author:
ISBN: 9535109634 9535170791 Year: 2013 Publisher: IntechOpen

Loading...
Export citation

Choose an application

Bookmark

Abstract

Angiogenesis is an extension process of the cardiovascular network within human body. It is usually triggered by the demand of oxygen and nutrients from the fast growing tissue and uncontrollably dividing cells, as seen during wound healing and tumor progression. This book focuses on tumor angiogenesis and includes 8 chapters written by highly experienced scholars from five different countries. It is the goal of this book to provide readers with an update on the molecular and cellular mechanisms of this biological process and hopefully to point out some new research directions for future therapeutic adventure.


Book
Anti-angiogenesis strategies in cancer therapeutics
Authors: ---
ISBN: 0128026731 012802576X 9780128026731 9780128025765 Year: 2016 Publisher: London Academic Press is an imprint of Elsevier

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Le ciblage de la voie du VEGF
Authors: ---
ISBN: 2742013393 9782742013395 9782742008216 Year: 2012 Publisher: Montrouge, France ; Esher, England : John Libbey Eurotext,

Listing 1 - 10 of 29 << page
of 3
>>
Sort by